Product & Service
Pop up
About us
Products
R&D
Certificate
News
Contact us
中文版
MABs
Ocrelizumab
Name: Ocrelizumab
CAS :637334-45-3
Registration :
Structural formula:
Previous:
Ustekinumab
Next:
Pertuzumab
line
Copyright(C)2020,
Hangzhou Jinlan Pharm-Drugs Technology Co., Ltd.
All Rights Reserved.